Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KRISTIN Z HAUSHALTER

Allopathic & Osteopathic Physicians Dermatology

NPI
1396959599
CMS profile
153890
Location
MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,158.64

104 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,063.65 103
Education $94.99 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KRISTIN Z HAUSHALTER

NPI 1396959599 · CMS profile ID 153890

Allopathic & Osteopathic Physicians / Dermatology

MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396959599?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KRISTIN Z HAUSHALTER, NPI 1396959599, CMS profile ID 153890. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396959599?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). KRISTIN Z HAUSHALTER, NPI 1396959599, CMS profile ID 153890. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396959599?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
KRISTIN Z HAUSHALTER, NPI 1396959599, CMS profile ID 153890, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1396959599?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

104 matching records · $2,158.64 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 104 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 104.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Incyte Corporation $24.9708/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044212129 CMS
LEO Pharma Inc. $18.3008/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053480793 CMS
Dermavant Sciences, Inc. $15.6508/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991198403 CMS
Lilly USA, LLC $30.2808/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031771479 CMS
Lilly USA, LLC $1.6708/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031825473 CMS
Ascendis Pharma Inc $22.4407/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014554357 CMS
Lilly USA, LLC $27.8707/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031874707 CMS
ABBVIE INC. $21.9507/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997451107 CMS
Dermavant Sciences, Inc. $20.2407/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991198399 CMS
GENZYME CORPORATION $23.5606/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050072575 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $24.4206/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051616053 CMS
ABBVIE INC. $27.5706/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997451105 CMS
MAYNE PHARMA COMMERCIAL LLC $6.8906/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060889025 CMS
Regeneron Healthcare Solutions, Inc. $31.9506/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999206981 CMS
Ascendis Pharma Inc $15.9406/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014548199 CMS
Almirall LLC $17.0606/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038191177 CMS
Sun Pharmaceutical Industries Inc. $25.4906/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053898177 CMS
Incyte Corporation $23.3206/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044212105 CMS
Lilly USA, LLC $24.3705/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031852151 CMS
Sun Pharmaceutical Industries Inc. $3.1605/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053898173 CMS
Krystal Biotech Inc $27.2205/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1008808721 CMS
PFIZER INC. $23.6905/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050365051 CMS
ABBVIE INC. $23.0805/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997451103 CMS
LEO Pharma Inc. $18.6405/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053480787 CMS
GENZYME CORPORATION $19.4605/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050072535 CMS
Dermavant Sciences, Inc. $17.4704/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991198395 CMS
MAYNE PHARMA COMMERCIAL LLC $6.1704/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060889029 CMS
Galderma Laboratories, L.P. $19.2104/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059701239 CMS
Incyte Corporation $27.9204/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044212075 CMS
Arcutis Biotherapeutics, Inc. $22.8704/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044768747 CMS
ABBVIE INC. $23.1504/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997451101 CMS
MAYNE PHARMA COMMERCIAL LLC $6.5004/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060889031 CMS
Lilly USA, LLC $23.7504/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031742733 CMS
Regeneron Healthcare Solutions, Inc. $29.5903/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999206977 CMS
Galderma Laboratories, L.P. $18.4103/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059701235 CMS
Eton Pharmaceuticals, Inc. $34.5603/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039005499 CMS
LEO Pharma Inc. $19.1603/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053480781 CMS
GENZYME CORPORATION $34.3303/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050072459 CMS
ABBVIE INC. $23.2703/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997451099 CMS
MAYNE PHARMA COMMERCIAL LLC $7.5503/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060889027 CMS
PFIZER INC. $22.5703/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049308707 CMS
Galderma Laboratories, L.P. $20.3603/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059701233 CMS
Sun Pharmaceutical Industries Inc. $25.1003/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053898169 CMS
ABBVIE INC. $32.1802/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997451097 CMS
Incyte Corporation $21.1002/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044212013 CMS
PFIZER INC. $24.2802/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050509897 CMS
Almirall LLC $18.5502/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038191371 CMS
Regeneron Healthcare Solutions, Inc. $28.7401/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999206973 CMS
Sun Pharmaceutical Industries Inc. $4.6001/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053898163 CMS
Incyte Corporation $14.6601/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044212003 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,307.70 77
PY2020 $1,798.65 104
PY2021 $1,940.32 85
PY2022 $1,816.70 86
PY2023 $2,158.64 104
PY2024 $2,683.08 129
PY2025 $3,243.12 150

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $216,340.52 23
PY2024 Principal investigator $23,200.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

23 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,975.52 12/04/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202528532
Principal investigator 1 ABBVIE INC. $4,400.00 11/20/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202525032
Principal investigator 1 ABBVIE INC. $6,335.64 11/05/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202523045
Principal investigator 1 ABBVIE INC. $8,572.86 10/09/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202515887
Principal investigator 1 ABBVIE INC. $11,096.82 09/04/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202509788
Principal investigator 1 ABBVIE INC. $1,000.00 08/28/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202506411
Principal investigator 1 ABBVIE INC. $800.00 08/14/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202504741
Principal investigator 1 ABBVIE INC. $2,121.06 08/06/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202502428
Principal investigator 1 ABBVIE INC. $3,350.00 07/17/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202498732
Principal investigator 1 ABBVIE INC. $3,684.84 07/08/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202497368
Principal investigator 1 ABBVIE INC. $1,600.00 06/11/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202490893
Principal investigator 1 ABBVIE INC. $2,469.36 06/03/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202489173
Principal investigator 1 Eli Lilly and Company $10,986.12 05/27/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF SOUTH FLORIDA LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN ADULT AND ADOLESCENT PARTICIPANTS WITH MODERATE-TO-SEVERE ATOPIC HAND AND FOOT DERMATITIS No dispute reported 06/30/2026 1187889164
Principal investigator 1 Eli Lilly and Company $104,381.00 05/12/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF SOUTH FLORIDA LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN ADULT AND ADOLESCENT PARTICIPANTS WITH MODERATE-TO-SEVERE ATOPIC HAND AND FOOT DERMATITIS No dispute reported 06/30/2026 1187889810
Principal investigator 1 ABBVIE INC. $10,163.70 05/07/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202484123
Principal investigator 1 ABBVIE INC. $1,600.00 04/17/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202477524
Principal investigator 1 ABBVIE INC. $5,421.60 04/17/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202477528
Principal investigator 1 ABBVIE INC. $594.00 03/27/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
M24-727 - A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202466899
Principal investigator 1 ABBVIE INC. $2,900.00 03/13/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
M24-601 - A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202463539
Principal investigator 1 ABBVIE INC. $16,500.00 03/07/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
M24-727 - A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202461435
Principal investigator 1 ABBVIE INC. $5,288.00 03/06/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
M24-727 - A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202458192
Principal investigator 1 ABBVIE INC. $3,500.00 02/24/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
M24-601 - A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202453657
Principal investigator 1 ABBVIE INC. $3,600.00 02/24/2025 Non-covered Recipient Entity
RESEARCH ASSOCIATES OF S FLO LLC
M24-601 - A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202453661